NCT05041946View on ClinicalTrials.gov

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

July 16, 2003

Primary Completion Date

December 15, 2004

Study Completion Date

November 19, 2021

Conditions

FatigueCancer

Interventions

DRUG

Methylphenidate

Given PO

OTHER

Placebo (Sugar Pill)

Given PO

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT05041946 - Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial | Biotech Hunter | Biotech Hunter